Antonio Henriques
@antoniohenriques.bsky.social
Founder & CEO of Momentum Therapeutics
Developing drugs for neurodegeneration and aging
Ex-Genentech, Amgen, Sanofi | Boston
Developing drugs for neurodegeneration and aging
Ex-Genentech, Amgen, Sanofi | Boston
I would actually be curious to understand what sets the biotechs with 24+ months of cash apart in this environment. AI-focused companies? Products of large VC firm incubators? Another common thread driving their extended runway?
November 24, 2024 at 10:37 PM
I would actually be curious to understand what sets the biotechs with 24+ months of cash apart in this environment. AI-focused companies? Products of large VC firm incubators? Another common thread driving their extended runway?
Would love to join!
November 23, 2024 at 4:41 PM
Would love to join!
Awesome, thank you!
November 20, 2024 at 2:43 AM
Awesome, thank you!
Nice, thanks!
November 20, 2024 at 2:42 AM
Nice, thanks!